AmCad BioMed Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
AmCad BioMed Corp announces change of general manager and head of finance
AmCad BioMed Corp:Says change of general manager from Chen Kuanchi to Chen Zhenggang.Says effective date will be announced later.Appoints Hong Weitang as new head of finance, replacing Wen Junyi, effective Feb. 21.
Latest Key Developments in Advanced
- Share this
- Digg this